James G. Kublin MD 483, Apr 2015

James G. Kublin MD 483, Apr 2015

Kathryn Krentz FDA$119.00

FDA investigators audited the James G. Kublin MD facility in Seattle, WA, United States and issued inspectional observations (via FDA 483) on 23 Apr 2015.

Buy This DocumentBuy 1-Year 483 Access

Product details

  • Inspection end: 23 Apr 2015
  • Location: Seattle, United States